Els Lierman
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 11
- Chronic Myeloid Leukemia Treatments 11
- Rheumatology 10
- Eosinophilic Disorders and Syndromes 10
- Co-authors
- Jan Cools (10 shared papers)Peter Vandenberghe (11 shared papers)Peter Marynen (3 shared papers)Helen Van Miegroet (3 shared papers)Nicole Mentens (2 shared papers)Lucienne Michaux (8 shared papers)P. Pierre (2 shared papers)Idoya Lahortiga (1 shared paper)
- Journals
- Haematologica (6 papers)Blood (3 papers)Expert Review of Anticancer Therapy (1 paper)British Journal of Haematology (1 paper)Cancers (1 paper)
- Partner nations
- BelgiumPolandUnited Kingdom
In The Last Decade
Els Lierman
16 papers receiving 443 citations
Peers
Comparison fields: 5 of 41
- Hematology 191
- Genetics 156
- Rheumatology 207
- Immunology 79
- Pulmonary and Respiratory Medicine 101
Countries citing papers authored by Els Lierman
This map shows the geographic impact of Els Lierman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els Lierman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els Lierman more than expected).
Fields of papers citing papers by Els Lierman
This network shows the impact of papers produced by Els Lierman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els Lierman. The network helps show where Els Lierman may publish in the future.
Co-authors
The 25 scholars most cited alongside Els Lierman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 102 | |
| 2 | 2009 | 81 | |
| 3 | 2007 | 68 | |
| 4 | 2011 | 43 | |
| 5 | 2015 | 39 | |
| 6 | 2014 | 37 | |
| 7 | 2019 | 30 | |
| 8 | 2018 | 14 | |
| 9 | 2009 | 13 | |
| 10 | 2018 | 10 | |
| 11 | 2009 | 8 | |
| 12 | 2017 | 3 | |
| 13 | 2019 | 2 | |
| 14 | Management of molecular resistance in a patient with fip1l1-pdgfra positive eosinophilic leukemia | 2008 | 1 |
| 15 | Downstream effectors of FIP1L1-PDGFRA as targets for therapy in chronic eosinophilic leukemia | 2010 | 1 |
| 16 | 2010 | 1 | |
| 17 | 2024 | 0 | |
| 18 | 2021 | 0 | |
| 19 | 2015 | 0 |
About Els Lierman
Els Lierman is a scholar working on Hematology, Rheumatology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 453 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Eosinophilic Disorders and Syndromes (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Mast cells and histamine (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hematology (191 citations), Genetics (156 citations), Rheumatology (207 citations), Immunology (79 citations) and Pulmonary and Respiratory Medicine (101 citations). Els Lierman has collaborated with scholars based in Belgium, Poland and United Kingdom. Frequent co-authors include Jan Cools, Peter Vandenberghe, Peter Marynen, Helen Van Miegroet, Nicole Mentens, Lucienne Michaux, P. Pierre, Idoya Lahortiga, Elizabeth H. Stover and Cedric Folens. Their work appears in journals such as Haematologica, Blood, Expert Review of Anticancer Therapy, British Journal of Haematology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.